glp-1 company China approval for Eli Lilly pill to come as soon as 2026, executive says The U.S. Food and Drug

Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat

The Federal Register notice for this proposal was published in early May 2026

Supplement Alternatives For Ozempic Several natural supplements may provide similar benefits to Ozempic by aiding blood sugar control and appetite regulation: Berberine Often compared to metformin, berberine helps control blood sugar and may support weight loss

The use of a GLP-1 medication helped aid in her weight loss which improved her insulin sensitivity and regulated her sugar levels

Image Credit: rasamma / Shutterstock A recent study published in the journal Pharmacological Research reviewed evidence on the effects of glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) on skeletal muscle (SM) mass, quality, and function